Citation & Authors
Front Immunol. 2025;16:1624223.
ABSTRACT · CHINESE TRANSLATION
Translated abstract
Translated from the licensed abstract via the Chinese version. This is not an official journal translation.
purpose
To compare chronic obstructive pulmonary disease (COPD) risk in patients newly diagnosed with rheumatoid arthritis (RA) and individuals without RA. This large study used robust propensity score matching to evaluate the influence of clinical factors and medications on COPD risk, providing further insight into the RA–COPD association.
method
This retrospective comparative cohort study used TriNetX Research Network data retrieved on October 9, 2023. Patients newly diagnosed with RA during 2010–2021 were compared with non-RA individuals matched for demographic characteristics and medical history. Propensity score matching balanced baseline covariates. The primary outcome was incident COPD within 5 years (ICD-10: J41–J44), analyzed using Kaplan–Meier methods and Cox proportional hazards models.
result
The study included 136,820 matched pairs of patients with and without RA. The 5-year cumulative probabilities of COPD were 7.36% and 5.97%, respectively, with an HR of 1.228 (95% CI 1.186–1.272). Patients with RA had higher COPD risks across demographic and clinical subgroups. Male sex, older age, higher rheumatoid factor, and higher erythrocyte sedimentation rate were associated with increased risk, while disease-modifying antirheumatic drugs and systemic nonsteroidal anti-inflammatory drugs were associated with lower risk.
Conclusion
Patients with RA had a significantly higher risk of COPD than individuals without RA, highlighting the importance of COPD prevention and management in this population.
Original work: Author of the above paper. Source:Public Summary ↗. This translation is based on the Chinese rendering of the original English abstract.
Original work license:CC BY ↗;Translations are subject to the same licensing conditions.
